Gender-Related Safety and Outcome in Advanced NSCLC Patients Treated with Immune Checkpoint-Inhibitors. A Real-World Experience

被引：0
|
作者：
Pizzutilo, P. [1 ]
Catino, A. [1 ]
Montrone, M. [1 ]
Longo, V. [1 ]
Ricci, D. [1 ]
Pesola, F. [1 ]
Marech, I. [1 ]
Mastrandrea, A. [1 ]
Petrillo, P. [1 ]
Zacheo, A. [1 ]
Varesano, N. [1 ]
Lamorgese, V. [1 ]
Bafunno, D. [1 ]
Galetta, D. [1 ]
机构：
[1] IRCCS Ist Tumori Giovanni Paolo II, Thorac Oncol, Thorac Oncol Unit, Bari, Italy
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 03期
关键词：
Immune checkpoint inhibitors; Gender-related outcome; advanced lung cancer;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P75.14
引用
收藏
页码：S579 / S580
页数：2
相关论文
共 50 条
  • [21] Consistent Patterns of Immune-Related Adverse Events in Postmortem and Real-World Data on Immune Checkpoint Inhibitors
    Frey, Connor
    MODERN PATHOLOGY, 2025, 38 (04)
  • [22] Delayed immune-related adverse events profile associated with immune checkpoint inhibitors: a real-world analysis
    Yang, Yana
    Li, Linman
    Tian, Jing
    Ma, Linwen
    Wu, Yaoxin
    Luo, Qian
    Luo, Yan
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [23] Predictors of immune-related adverse events and outcomes in patients with NSCLC treated with immune-checkpoint inhibitors
    Serino, M.
    Freitas, C.
    Martins, M.
    Ferreira, P.
    Cardoso, C.
    Veiga, F.
    Santos, V.
    Araujo, D.
    Novais-Bastos, H.
    Magalhaes, A.
    Queiroga, H.
    Fernandes, G.
    Hespanhol, V.
    PULMONOLOGY, 2024, 30 (04): : 352 - 361
  • [24] Baseline metabolic tumor burden on FDG PET/CT scans predicts outcome in advanced NSCLC patients treated with immune checkpoint inhibitors
    Romain-David Seban
    Laura Mezquita
    Arnaud Berenbaum
    Laurent Dercle
    Angela Botticella
    Cécile Le Pechoux
    Caroline Caramella
    Eric Deutsch
    Serena Grimaldi
    Julien Adam
    Samy Ammari
    David Planchard
    Sophie Leboulleux
    Benjamin Besse
    European Journal of Nuclear Medicine and Molecular Imaging, 2020, 47 : 1147 - 1157
  • [25] Real-World Impact of Immune Checkpoint Inhibitors in Metastatic Uveal Melanoma
    Bol, Kalijn Fredrike
    Ellebaek, Eva
    Hoejberg, Lise
    Bagger, Mette Marie
    Larsen, Mathilde Skaarup
    Klausen, Tobias Wirenfeldt
    Kohler, Ulrich Heide
    Schmidt, Henrik
    Bastholt, Lars
    Kiilgaard, Jens Folke
    Donia, Marco
    Svane, Inge Marie
    CANCERS, 2019, 11 (10)
  • [26] Immune checkpoint inhibitors-related endocrinopathies exhibit increased severity in breast cancer patients: a real-world study
    Gao, Rili
    Li, Cheukfai
    Zhang, Shuting
    Liao, Ning
    Guan, Haixia
    ENDOCRINE, 2024, 85 (03) : 1446 - 1455
  • [27] Baseline metabolic tumor burden on FDG PET/CT scans predicts outcome in advanced NSCLC patients treated with immune checkpoint inhibitors
    Seban, Romain-David
    Mezquita, Laura
    Berenbaum, Arnaud
    Dercle, Laurent
    Botticella, Angela
    Le Pechoux, Cecile
    Caramella, Caroline
    Deutsch, Eric
    Grimaldi, Serena
    Adam, Julien
    Ammari, Samy
    Planchard, David
    Leboulleux, Sophie
    Besse, Benjamin
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (05) : 1147 - 1157
  • [28] Impact of immune checkpoint inhibitors on survival outcomes in advanced gastric cancer in Japan: A real-world analysis
    Kadono, Toru
    Iwasa, Satoru
    Hirose, Toshiharu
    Hirano, Hidekazu
    Okita, Natsuko
    Shoji, Hirokazu
    Takashima, Atsuo
    Kato, Ken
    CANCER MEDICINE, 2024, 13 (12):
  • [29] Efficacy and safety of immune checkpoint inhibitors in advanced pancreatic cancer: A real world study in Chinese cohort
    Gong, Xiaoling
    Zhu, Yahui
    Zhang, Qianning
    Qiu, Xin
    Lu, Changchang
    Tong, Fan
    Wang, Qiaoli
    Kong, Weiwei
    Zhou, Haihui
    Liu, Baorui
    Zhou, Yujie
    Du, Juan
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (06)
  • [30] Acute kidney injury in patients receiving immune checkpoint inhibitors: a retrospective real-world study
    Lumlertgul, Nuttha
    Vassallo, Pietro
    Tydeman, Florence
    Lewis, Natasha
    Hobill, Abigail
    Weerapolchai, Kittisak
    Nordin, Nurul Zaynah
    Seylanova, Nina
    Martin, Luke
    Cennamo, Armando
    Wang, Yanzhong
    Rigg, Anne
    Shaunak, Nisha
    Ostermann, Marlies
    EUROPEAN JOURNAL OF CANCER, 2023, 191
12345